Top Markets
Coin of the day
Imaging Biometrics Ltd. Imaging Biometrics Ltd.

Imaging Biometrics Ltd.

IBAI
Classement en actions #41258
Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier,... Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and the United States. Its operations are structured into three main segments: a Holding Company, Medical Software, and Oral Gallium Maltolate (GaM). The Medical Software division develops a comprehensive suite of ready-to-use software applications for the healthcare sector. This portfolio includes IB Clinic, which serves as the foundational platform for all IB software; IB Neuro, a specialized platform for MR DSC perfusion processing; and IB Delta Suite, designed to generate Delta T1 maps from routine MR examinations. Further offerings comprise IB DCE and IB Diffusion, both providing in-depth insights into blood flow and water diffusion throughout the body. For non-invasive assessments, the company provides StoneChecker and Liver Surface Nodularity, which are computed tomography (CT) processing tools that assist clinicians in evaluating kidney stones and liver health. Additional software includes IB ASL, used to measure cerebral blood flow for diagnosing conditions like stroke and dementia, and IB Zero G, an innovative technology that eliminates the need for gadolinium contrast agents in standard imaging. The suite also features IB Nimble, facilitating virtual collaboration among healthcare professionals. Beyond software, the company's Oral Gallium Maltolate (GaM) segment is actively pursuing the development of IB003, a gallium maltolate drug candidate currently in Phase 1 clinical trials for treating glioblastoma. Imaging Biometrics Ltd. also offers consulting services. The entity, which was previously known as IQ-AI Limited, is slated to adopt the name Imaging Biometrics Ltd. in May 2025.
Prix de l'action
$0.01197417
Capitalisation boursière
$29.54K
Changement (1 jour)
13.55%
Changement (1 an)
22.84%
Pays
JE
Échange Imaging Biometrics Ltd. (IBAI)

Catégorie

Bénéfices pour Imaging Biometrics Ltd. (IBAI)
Bénéfices en Dec 2024 TTM : $-410.46K
Selon les derniers rapports financiers de Imaging Biometrics Ltd., les bénéfices actuels de l'entreprise sont de $-410.46K. En 2023, l'entreprise a réalisé un bénéfice de $-794.12K, une diminution par rapport à celui de 2022 qui était de $-618.93K. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Imaging Biometrics Ltd. de 2000 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-410.46K 0.00%
2024 $-410.46K -48.31%
2023 $-794.12K 28.30%
2022 $-618.93K -8.63%
2021 $-677.43K -30.95%
2020 $-981.01K 19.89%
2019 $-818.28K -15.92%
2018 $-973.21K 156.28%
2017 $-379.74K 1.55%
2016 $-373.95K 65.86%
2015 $-225.46K -91.83%
2014 $-2.76M 30.57%
2013 $-2.11M -34.34%
2012 $-3.22M -36.11%
2011 $-5.04M -11.72%
2010 $-5.71M -247.39%
2009 $3.87M -122.26%
2008 $-17.39M -341.35%
2007 $7.21M -30.26%
2006 $10.33M 13.84%
2005 $9.08M -18.18%
2004 $11.09M 11.31%
2003 $9.96M 37.33%
2002 $7.26M 10.81%
2001 $6.55M 8,021.63%
2000 $80.63K 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$2.04B -497,838.57%
US
$-259.89M 63,218.29%
US
$266.26M -64,968.52%
AU
$295.53M -72,100.82%
US
$-74.89M 18,145.54%
US